Data supporting a pilot high-throughput screen of a drug library for identification of DYRK1A inhibitors and high-content imaging analysis of identified harmine analogs.

Data supporting a pilot high-throughput screen of a drug library for identification of DYRK1A inhibitors and high-content imaging analysis of identified harmine analogs.
复制标题

DOI:
10.1016/j.dib.2021.107189
复制
发表时间:
2021-08
期刊:
影响因子:
1.2
通讯作者:
Williams KP
Williams KP
中科院分区:
其他
文献类型:
--
作者:
Tarpley M;Oladapo H;Caligan TB;Onyenwoke RU;Williams KP

文献摘要

参考文献

相似文献

The data presented in this article support the accompanying research article “Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies”. As DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1a) plays a role in the pathophysiology of a number of diseases including diabetes, cancer and neurodegeneration, the identification of DYRK1A inhibitors is of significant interest. This data article details the hits identified from a DYRK1A high-throughput screen of a small molecule compound library containing over 95% approved drugs. Twenty-two compounds were identified with >50% inhibition, including harmine and four of its analogs. Subsequent profiling of these harmine analogs using glioma cancer cell lines and high-content image analysis identified those with effects on growth and cytotoxicity.
DOI: 10.1016/j.canlet.2017.09.033
发表时间: 2017-12-28
期刊: Cancer letters
影响因子: 9.7
作者:
Oladapo HO;Tarpley M;Sauer SJ;Addo KA;Ingram SM;Strepay D;Ehe BK;Chdid L;Trinkler M;Roques JR;Darr DB;Fleming JM;Devi GR;Williams KP
通讯作者: Williams KP
DOI: 10.1007/s00125-014-3174-3
发表时间: 2014-05-01
期刊: DIABETOLOGIA
影响因子: 8.2
作者:
Rachdi, Latif;Kariyawasam, Dulanjalee;Scharfmann, Raphael
通讯作者: Scharfmann, Raphael
DOI: 10.1016/j.ejps.2021.105821
发表时间: 2021-07-01
期刊: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
影响因子: --
作者:
Tarpley M;Oladapo HO;Strepay D;Caligan TB;Chdid L;Shehata H;Roques JR;Thomas R;Laudeman CP;Onyenwoke RU;Darr DB;Williams KP
通讯作者: Williams KP
DOI: 10.1177/1087057108318428
发表时间: 2008-07-01
影响因子: --
作者:
Abraham, Vivek C.;Towne, Danli L.;Burns, David J.
通讯作者: Burns, David J.
DOI: 10.1016/j.mex.2021.101383
发表时间: 2021
期刊: MethodsX
影响因子: 1.9
作者:
Tarpley M;Caligan TB;Onyenwoke RU;Williams KP
通讯作者: Williams KP